News

Micell Technologies Inc. announced that a peer reviewed article discussing imaging and clinical results of the...

stents peripheral peripheral artery disease pad clinical trial study bioflex

Biotronik announced it has completed patient enrollment in the iliac arm of its Bioflex-I trial. Under the supervision of Mark Burket, M.D. and chief, Cardiovascular Division at the University of...

Emergency surgery and advanced cardiac disease are risk factors for major adverse cardiac events (MACE) after noncardiac surgery in patients with recent coronary stent ...

Physicians at the Heart Hospital of Austin, enrolled and successfully treated the first patient in the Roadster study, a global, multicenter ...

Enabler-C, EndoCross, enabler catheter

EndoCross, Ltd. announced today that it has already enrolled one-third of the patients planned for the first-in-human study of its Enabler-C Catheter System for Crossing Coronary Chronic Total...

Cath Lab pharmaceuticals clinical trial study CNIC spain icahn heart attack

Early treatment of heart attack patients with an inexpensive beta-blocker drug called metoprolol, while in transit to the hospital, can significantly reduce damage to the heart during a...

Sunshine Heart Inc. has launched a website dedicated to providing information to patients suffering from moderate to severe heart...

A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per month to allow trials of different sizes and durations to be compared easily. This measurement...

CTA, CCTA, CT angiography

A large number of emergency room visits are for chest pain evaluation, and many hospitals are adopting CT angiography as a primary test to quickly rule-out coronary disease.

Patient enrollment has been initiated in a post-market registry for the COMBO Dual Therapy Stent to evaluate its long-term safety and performance in routine clinical practice. The...

Rox Medical has crossed the halfway point in the CONTROL-HTN international, multi-center, randomized controlled hypertension trial. The milestone was met with the enrollment of the first patient...

Medicare Expenses Growth Heart Attack Patients 1998 2008

Medicare expenses for patients with acute myocardial infarction (AMI, heart attack) increased substantially between 1998 and 2008, with much of the increase coming in expenses 31 days or more...

Icahn School of Medicine at Mount Sinai PARIS Study Antiplatelet Therapy PCI

Lead study investigators from Icahn School of Medicine at Mount Sinai presented their Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients (PARIS) study findings at the ESC...

Biotronik, home monitoring, Biotronik Home Monitoring, BIOTRONIK

Biotronik announced the highly-anticipated results of the Reform study. The study demonstrates that ICD (implantable cardioverter-defibrillator) patients with Biotronik's Home Monitoring...

A new study of patients who died of sudden cardiac arrest, a usually fatal condition that causes the heart to stop beating, shows the majority who qualified to receive potentially lifesaving...

Gore Carotid Stenting SCAFFOLD Clinical Trial Stroke Treatment Cath Lab

W. L. Gore & Associates has enrolled the first patient in its Gore Carotid Stent clinical study for the treatment of carotid Artery stenosis in patients at increased risk For...

aortic valve, Edwards Lifesciences, SAPIEN, SAPIEN aortic valve

Edwards announced a new post-hoc data analysis from The PARTNER Trial demonstrated that diabetic patients with aortic stenosis in need of heart valve replacement, but at high surgical risk,...

abbott vascular, abbott laboratories, abbott bioresorbable stents

The Mount Sinai Medical Center is participating in the nationwide Absorb III clinical trial testing the performance and potential clinical benefits of a fully dissolvable and temporary...

Corindus CorPath 200 RECISION Registry Clinical Trial

Corindus Vascular Robotics announced the PRECISION Registry, an ongoing study aimed at collecting data on the patterns of use, safety and effectiveness in the delivery and manipulation of...

Lotus Valve System, heart valves, Boston Scientific Corporation

Boston Scientific reported favorable six-month results from the first 60 patients enrolled in the REPRISE II clinical trial evaluating the safety and performance of the Lotus Valve System in...